Mayo Clinic-TGen study role testosterone may play in triple negative breast cancer

Study presented Friday at 65th annual meeting of Society of Surgical Oncology

2012-03-26

(Press-News.org) SCOTTSDALE, Ariz. -- Could blocking a testosterone receptor lead to a new way to treat an aggressive form of breast cancer? That's a question researchers at Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) are exploring. Preliminary results of a Mayo Clinic - TGen collaborative study shows the testosterone receptor may be a potential target to attack in treating triple negative breast cancer (TNBC).

Lead researcher Barbara Pockaj, M.D., a surgical oncologist at Mayo Clinic in Arizona will present the results of the study at the 65th annual Society of Surgical Oncology conference on March 23 in Orlando, Fla.

TNBC is highly aggressive and affects approximately 10 to 20 percent of breast cancer patients. The disease is characterized by larger, faster-growing tumors than other types of breast cancer and has limited treatment options.

Unlike other forms of breast cancer in which treatments are tailored to specifically target hormone receptors such as estrogen and progesterone or the HER-2 proteins that promote the growth and spread of cancer cells, triple negative cancer cells do not possess markers for estrogen, progesterone or HER-2, Dr. Pockaj says. There are no targeted therapies other than chemotherapy to TNBC, she says.

Researchers at Mayo Clinic and TGen say that could change if the androgen (testosterone) receptor shows potential as a therapeutic target.

"The goal of the study was to define what may be fueling TNBC, thereby identifying new potential options for effective targeted treatment," says co-lead researcher Heather Cunliffe, Ph.D., Associate Professor and head of TGen's breast and ovarian cancer research unit. "The team discovered that the androgen receptor is expressed in a significant proportion of these tumors, and moreover, the androgen-receptive positive tumors shared a unique clinical behavior."

Researchers found 22 percent of the patients with TNBC had the androgen receptor in their tumors.

"These cancers appeared in women who were older and there was a higher likelihood of the cancer spreading to the lymph nodes. Even though the women with androgen-receptor positive TNBC had more aggressive cancer to start, their survival was no different than patients with TNBC whose cancers did not possess the androgen receptor," Dr. Pockaj says. "Importantly, while all normal breast tissue had androgen receptors, it was lost in the majority of patients with TNBC. Our data shows us that there is a definitive group of patients who may be sensitive to treatment directed against the androgen receptor."

While further research with a larger number of patients is needed to define clinical implications of androgen receptor positive TNBC, Dr. Cunliffe says this study provides important insights.

An important next step of the research will be to determine how the androgen receptor functions in TNBC.

"We will look at all the genes within the cancer cells from each patient using genomic approaches. This way we can find ways to manipulate the cancer cell which hopefully will translate into new treatment strategies for the women with TNBC," Dr. Pockaj says.

###The study was supported by a seed grant from the joint Mayo Clinic-TGen collaborative research program.

VIDEO ALERT: Click here to watch Dr. Barbara Pockaj explain the study.

About Mayo Clinic Mayo Clinic is a non-profit worldwide leader in medical care, research, and education for people from all walks of life. For more information, visit www.mayoclinic.org/about/ and www.mayoclinic.org/news.

About The Translational Genomics Research Institute The Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. Research at TGen is focused on helping patients with diseases such as cancer, neurological disorders and diabetes. TGen is on the cutting edge of translational research where investigators are able to unravel the genetic components of common and complex diseases. Working with collaborators in the scientific and medical communities, TGen believes it can make a substantial contribution to the efficiency and effectiveness of the translational process. For more information, visit: www.tgen.org.

Press Contacts:

Julie Janovsky-Mason
Mayo Clinic
480-301-4222
janovsky-mason.julie@mayo.edu

Steve Yozwiak
TGen
602-343-8704
syozwiak@tgen.org

ELSE PRESS RELEASES FROM THIS DATE:

Magnetic field researchers target 100-tesla goal

2012-03-26

LOS ALAMOS, New Mexico, March 22, 2012 -- Researchers at Los Alamos National Laboratory's biggest magnet facility today met the grand challenge of producing magnetic fields in excess of 100 tesla while conducting six different experiments. The hundred-tesla level is roughly equivalent to 2 million times Earth's magnetic field. "This is our moon shot, we've worked toward this for a decade and a half," said Chuck Mielke, director of the Pulsed Field Facility at Los Alamos. The team used the 100-tesla pulsed, multi-shot magnet, a combination of seven coils sets weighing ...

Diatom biosensor could shine light on future nanomaterials

2012-03-26

SEQUIM, Wash. – A glow coming from the glassy shell of microscopic marine algae called diatoms could someday help us detect chemicals and other substances in water samples. And the fact that this diatom can glow in response to an external substance could also help researchers develop a variety of new, diatom-inspired nanomaterials that could solve problems in sensing, catalysis and environmental remediation. Fluorescence is the key characteristic of a new biosensor developed by researchers at the Department of Energy's Pacific Northwest National Laboratory. The biosensor, ...

Ancient civilizations reveal ways to manage fisheries for sustainability

2012-03-26

In the search for sustainability of the ocean's fisheries, solutions can be found in a surprising place: the ancient past. In a study published on March 23 in the journal Fish and Fisheries, a team of marine scientists reconstructed fisheries yields over seven centuries of human habitation in Hawaii and the Florida Keys, the largest coral reef ecosystems in the United States, and evaluated the management strategies associated with periods of sustainability. The results surprised them. "Before European contact, Native Hawaiians were catching fish at rates that far ...

Adner Colon Attend Exclusive Action Freedom Legacy Mastermind Event at Hasbrouck Heights, NJ

2012-03-26

Online Marketing Entrepreneur Adner Colon knew his life would change when he joined Carbon Copy Pro in February 2012 but not in the way he expected. Online Marketing Entrepreneur Adner Colon knew his life would change when he joined Carbon Copy Pro in February 2012 but not in the way he expected. On March 24th and 25th Adner Colon will be attending an exclusive Action Freedom Legacy (AFL) Legacy Mastermind event at Hasbrouck Heights. The trainers for the event are Aaron and Sophia Raskin and members of the Loyal 9 who are top producers in the online marketing industry. Here's ...

Low serum adiponectin levels predict future risk for asthma in women

2012-03-26

Low serum adiponectin levels predict an increased future risk for developing asthma in middle-aged women, particularly among smokers, according to a new study. "Adiposity is known to be related to asthma. Although a causal link between adiponectin (a protein produced by adipose tissue) and asthma has been demonstrated in mice, the evidence in humans has been conflicting," said lead author Akshay Sood, MD, MPH, associate professor in the Division of Pulmonary and Critical Care Medicine at the University of New Mexico Health Sciences Center School of Medicine. "In an ...

Periodontal therapy reduces hospitalizations and medical care costs in diabetics

2012-03-26

Tampa, Fla., USA – Today, during the 41st Annual Meeting & Exhibition of the American Association for Dental Research (AADR), held in conjunction with the 36th Annual Meeting of the Canadian Association for Dental Research, an abstract titled "Periodontal Therapy Reduces Hospitalizations and Medical Care Costs in Diabetics" to determine if periodontal treatment was associated with the number of hospitalizations and cost of medical care among diabetics with periodontal disease. A longitudinal study compared medical costs for diabetic subjects with periodontal disease ...

Study: Preoperative estrogen-blocking therapy may preempt need for mastectomy

2012-03-26

Orlando – March 23, 2012. Preoperative treatment with aromatase inhibitors increases the likelihood that postmenopausal women with estrogen receptor-positive breast cancer will be able to have breast-conserving surgery rather than a mastectomy, according to the results of a national clinical trial presented today at the Society of Surgical Oncology annual meeting in Orlando, Fla. "We found that half of the postmenopausal women in the study who initially faced having a mastectomy were able to have breast-conserving surgery after being treated for four months with an aromatase ...

New epilepsy gene located in dogs

2012-03-26

A new epilepsy gene for idiopathic epilepsy in Belgian Shepherds has been found in the canine chromosome 37. The research of Professor Hannes Lohi and his group conducted at the University of Helsinki and the Folkhälsan Research Center opens new avenues for the understanding of the genetic background of the most common canine epilepsies. The research also has an impact on the understanding of common epilepsies in humans. The research is published in the scientific journal PLoS ONE on March 23, 2012. Epilepsy affects about 1-5% of the human population at some stage of ...

Overweight and obese women at greater risk of breast cancer recurrence

2012-03-26

Vienna, Austria: Women who are overweight or obese when they are diagnosed with breast cancer are at higher risk of cancer recurrence or related death than are leaner women, according to a new study to be presented to the 8th European Breast Cancer Conference (EBCC-8) today (Friday). This finding held true even though the study mandated that chemotherapy dosage be adjusted for body weight, and adds further to the evidence that lifestyle factors can influence cancer prognosis, a researcher will tell the conference. Dr. Jennifer Ligibel, a medical oncologist at the Dana-Farber ...

Mike Hoesly Attends Legacy Mastermind

2012-03-26

On March 24, 2012 Mike Hoesly attended the Legacy Mastermind in Hasbrouck Heights, NJ. The mastermind is a group of 20 internet marketers getting together to share industry secrets and tips of the trade. The Loyal 9 Revolution and Team Rashkin are leading the event. These two groups have dominated the home business industry for the past few years drawing in hundreds of thousands of leads and millions of dollars as a result. Hoesly has attended many live events in the industry and the skills learned here will only add to his repertoire. Hoesly says," Live events ...

Mayo Clinic-TGen study role testosterone may play in triple negative breast cancer

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: